Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Orphanet Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol MAPK10 contributors: mct/pgu - updated : 20-06-2015
HGNC name mitogen-activated protein kinase 10
HGNC id 6872
Location 4q21.3      Physical location : 86.936.276 - 87.374.283
Synonym name
  • C-Jun kinase 3
  • stress activated protein kinase JNK3
  • stress activated protein kinase beta
  • MAP kinase p49 3F12
  • Synonym symbol(s) JNK3, PRKM10, P493F12, FLJ12099, FLJ33785, JNK3A, p54bSAPK, p493F12
    EC.number 2.7.11.24
    DNA
    TYPE functioning gene
    STRUCTURE 338.17 kb     13 Exon(s)
    10 Kb 5' upstream gene genomic sequence study
    regulatory sequence
    MAPPING cloned Y linked N status provisional
    RNA
    TRANSCRIPTS type messenger
    identificationnb exonstypebpproduct
    ProteinkDaAAspecific expressionYearPubmed
    14 splicing 4186 52 464 - 2011 22047447
  • JNK3- alpha 2, or variant 2
  • both nonvisual arrestins directly bind JNK3alpha2 and its upstream activator MAP2K4, and the affinity of ARR3 for these kinases is higher than that of ARR2
  • enhanced the association between ARR3 with MAP2K4 while reducing ARR3 binding to MAP2K7
  • 13 splicing 3727 47 422 - 2007 17680991
    JNK3- alpha 1 or variant 1
    14 - 4213 - 426 - 2007 17680991
    variant 3, or stress activated protein kinase beta
    9 - 3511 - 277 - 2007 17680991
    EXPRESSION
    Type widely
       expressed in (based on citations)
    organ(s)
    SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
    Cardiovascularheart   highly
    Nervousbraindiencephalonhypothalamus highly
     brainforebraincerebral cortex highly
     brainhindbraincerebellum highly
     spinal cord    
    Reproductivemale systemprostate  highly
    tissue
    SystemTissueTissue level 1Tissue level 2LevelPubmedSpeciesStageRna symbol
    Connectiveadipose   
    Muscularstriatumskeletal  
    Nervouscentral   
    Nervousperipherous   
    cells
    SystemCellPubmedSpeciesStageRna symbol
    Nervousneuron
    cell lineage
    cell lines
    fluid/secretion
    at STAGE
    PROTEIN
    PHYSICAL PROPERTIES
    STRUCTURE
    motifs/domains
  • tyrosine kinase catalytic domain
  • HOMOLOGY
    interspecies homolog to murine Mapk10
    Homologene
    FAMILY
  • protein kinase superfamily
  • CMGC Ser/Thr protein kinase family
  • MAP kinase subfamily
  • CATEGORY regulatory , signaling
    SUBCELLULAR LOCALIZATION     intracellular
    intracellular,cytoplasm,organelle,mitochondria
    intracellular,cytoplasm,cytosolic
    intracellular,nucleus,nucleoplasm
    basic FUNCTION
  • mediating apoptosis in central nervous system and role in the development of brain tumors
  • playing an established role in both neuronal differentiation and apoptosis
  • having a pivotal role in regulation of ceramide biosynthesis in cerebral ischemia/reperfusion
  • critical mediator of mutant HTT toxicity, providing a molecular basis for mutant HTT-induced inhibition of fast axonal transport
  • mediates activation of LASS6 in cerebral ischemia/reperfusion
  • critically involved in stress-induced deficit of contextual fear
  • important enzymes in the pathology of diverse neurological disorders
  • mediates potentially its effects mainly at the transcriptional level, while MAPK8 or MAPK9 appear to mediate their pro-apoptotic effect in the cytoplasm
  • CELLULAR PROCESS cell life, cell death/apoptosis
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component
  • components of the two MAPK cascades, MAP3K5-MAP2K4-MAPK10 and RAF1-MAPK1-MAP2K1 interacting with arrestins
  • INTERACTION
    DNA
    RNA
    small molecule
    protein
  • interacting with ARR3 (multiple residues on the non-receptor-binding side of ARR3 are crucial for MAPK10 activation)
  • protects beta-cells from apoptosis and dysfunction mainly through maintenance of a normal IRS2 to AKT2 signaling pathway
  • ARR3 binds MAPK10, MAP2K4, and MAP3K5
  • ARR3 promotes MAPK10 phosphorylation by MAP2K7
  • MAPK10 interacts with the non-receptor-binding side of ARR3
  • cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    constitutional   deletion    
    in pharmacoresistant epileptic encephalopathy type Lennox-Gastaut
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker PPP2CB, MAPK10, RAC3 were independent prognostic factors for bladder cancer (BLCA)
    Therapy target
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    constitutional   deletion    
    in pharmacoresistant epileptic encephalopathy type Lennox-Gastaut
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker PPP2CB, MAPK10, RAC3 were independent prognostic factors for bladder cancer (BLCA)
    Therapy target
    ANIMAL & CELL MODELS
  • Jnk3 null mice showed an increase in pik3cb transcript and protein, together with an increase in PI3K activity and phosphorylation of AKT